Home » Authors » Don Long

Articles by Don Long

Bioheart IPO will seek $46.9M to back cell therapy for heart

Oct. 2, 2007

Medtronic gets new questions, big patent penalty, lawsuit

Sep. 28, 2007

Device makers should be wary of tougher FDA drug powers

Sep. 24, 2007

New Cypher vs. Taxus vs. BMS study not great news for DES

Sep. 18, 2007

More than sacrifices, med-tech can contribute its innovations

Sep. 11, 2007

ICD registry points to clear need for implant procedure training

Sep. 10, 2007

SCAI issues new SCAAR data, now confident in DES safety

Sep. 6, 2007

SCAAR likely (or maybe not) to remove scar on DES future

Sep. 1, 2007

Boston Scientific: a buyout very much looking to happen?

Sep. 1, 2007

For Boston Scientific.... Two-month Odyssey of restructuring not likely to end soon

Sep. 1, 2007

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 10, 2026.
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld
Hematopoietic stem cell research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
Korsana boosts Alzheimer’s work with reverse merger, $380M financing
BioWorld Science
Just over a month after emerging from stealth and disclosing a $150 million series A, Korsana Biosciences Inc. is making the leap to the public market via a...